Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

amgen_flag

Amgen sues Novartis over Enbrel biosimilar

March 3, 2016 Research and Development, Sales and Marketing Amgen, Novartis, Sandoz, biosimilars

Amgen has filed a suit in a US court against Novartis’ generics unit Sandoz, in a bid to protect bestselling …
News
gardasil_9

CHMP recommends Sanofi’s two-dose schedule HPV vaccine

March 3, 2016 Research and Development HPV vaccine, MSD, Sanofi Pasteur

Sanofi Pasteur’s and MSD’s vaccine against human papillomavirus (HPV), Gardasil 9, has received a positive opinion from the European Medicine …
News
gilead-sciences

FDA approves Gilead’s Odefsey for treatment of HIV-1 infection

March 2, 2016 Research and Development, Sales and Marketing Gilead Sciences, HIV, Odefsey

Gilead Sciences has announced that the US Food and Drug Administration (FDA) has approved its TAF-based single tablet regimen Odefsey …
News
janssen_latest_logo_on_sign

Janssen slams NICE decision on Imbruvica

March 2, 2016 Research and Development, Sales and Marketing CLL, Cancer, Cancer Drugs Fund, Janssen, Johnson & Johnson, NICE, imbruvica

Janssen, the R&D arm of pharma major Johnson & Johnson, says it is extremely disappointed following regulator NICE’s announcement that …
News
humira_abbott_

Top 10 medicines issued in England by prescription cost in 2014-15

March 2, 2016 Research and Development, Sales and Marketing Cost, Humira, NHS, prescription

AbbVie, Humira (adalimumab), £371m. This drug treats a variety of conditions including psoriatic arthritics, Crohn’s disease and ulcerative colitis. The …
Feature
hilary_clinton_speaks_at_a_rally_in_des_moines_in_january

Clinton steps up attacks on Valeant in latest campaign advert

March 2, 2016 Research and Development, Sales and Marketing Hilary Clinton, Valeant

This is not the first time the pharma industry has drawn the ire of the US presidential hopefuls, but Hilary …
News
chi_med

Chi-Med starts Phase II trial for thyroid cancer drug

March 2, 2016 Research and Development Chi-Med

Hutchison China MediTech (Chi-Med) says its unit Hutchison MediPharma (HMP) has initiated mid-stage trials for sulfatinib to treat differentiated thyroid …
News
merck_innovation_centre

Merck begins late-stage trials of Humira biosimilar

March 2, 2016 Research and Development, Sales and Marketing AbbVie, Humira, Merck, biosimilars

Merck has announced the beginning of a global phase III study of its Humira (adalimumb) biosimilar, MSB11022, in chronic plaque …
News
ipsen_logo

Exelixis signs $200 million licensing deal for cancer drug

March 1, 2016 Research and Development, Sales and Marketing Cancer, Cometriq, Exelixis, ipsen

Exelixis has signed a licensing agreement with French biotech firm Ipsen for its cancer drug Cometriq (cabozantinib) for an upfront …
News
celgene_1_02

Two Celgene cancer drugs approved in Ireland

March 1, 2016 Research and Development, Sales and Marketing Abraxane, Cancer, Celgene, Revlimid, imnovid

Irish regulators have recommended two cancer treatments from Celgene: Imnovid (pomalidomide), in combination with dexamethasone, for previously-treated relapsed and refractory …
News
alzheimers

South Florida Uni begins £875,000 dementia drug research programme

March 1, 2016 Manufacturing and Production, Research and Development Alzheimer's

Funding from a consortium worth £875,000 pounds has helped kick start a new dementia drug research program at the University …
News
astellas

Japan approves Astellas hyperphosphatemia drug

March 1, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Astellas, Hyperphosphatemia, Japan, Kiklin

Astellas Pharma has received approval from the Ministry of Health, Labour and Welfare in Japan for a supplemental new drug …
News
valeant_logo_on_board

Valeant shares slide on SEC investigation announcement

March 1, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Philidore, Valeant, regulation

Shares at troubled Valeant plummeted some 20% Monday after the company said it was under investigation by the Securities and …
News
astrazeneca_plaque

AstraZeneca announces tremelimumab setback in mesothelioma test

March 1, 2016 Manufacturing and Production, Research and Development AstraZeneca, Cancer, MedImmune, tremelimumab

AstraZeneca and its global biologics research and development arm, MedImmune, have announced a setback in the result of their Phase …
News
gensight

GenSight begins Phase III retinal disease trials

February 29, 2016 Research and Development GenSight, Leber’s Hereditary Optic Neuropathy, retinal disease

French biotech GenSight has begun enrolling patients for two parallel pivotal Phase III trials with its lead candidate GS010, a …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026